Montalbano, John

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Montalbano, John's trades of Eupraxia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
211.68
Quantity 13,740 -7.0%
Value US$28,922
Transaction date
Purchase
Price
455.78
Quantity 39,414 -12.2%
Value US$1,302,588
Transaction date
Purchase
Price
213.71
Quantity 8,321 +19.6%
Value CA$4,464,789
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-19
B Purchase
13,740 -7.0%
211.68
US$28,922 		13,740 -7.0% 211.68 US$28,922
2025-09-24 2025-09-24
B Purchase
39,414 -12.2%
455.78
US$1,302,588 		39,414 -12.2% 455.78 US$1,302,588
2023-08-20 2023-08-18
B Purchase
8,321 +19.6%
213.71
CA$4,464,789 		8,321 +19.6% 213.71 CA$4,464,789
2022-09-07 2022-09-07
B Purchase
4,500 +0.4%
1.50
CA$6,750 		4,500 +0.4% 1.50 CA$6,750
2022-09-07 2022-09-06
B Purchase
1,600 +0.1%
1.50
CA$2,400 		1,600 +0.1% 1.50 CA$2,400